The Prevalence of Coronary Heart Disease, Stroke and Selected Co-Morbidities in Patients with Newly Diagnosed Type 2 Diabetes Population - Based on Cohort Study of Outpatients

1. Belicová M. Diabetes mellitus a srdce. In: Mokáň M, Martinka E, Galajda P, editors. Diabetes mellitus a vybrané metabolické ochorenia: 1nd ed. Martin: Vydavateľstvo P + M; 2008. kap. 10.1: p. 649 - 665.Search in Google Scholar

2. ADVANCE Collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560 - 2572 .10.1056/NEJMoa080298718539916Search in Google Scholar

3. Cefalu W, Watson K. Intensive glycemic control and cardiovascular disease observations. From the Accord Study. Now what can a clinician possible think. Diabetes 2008; 57: 1163 -1165 .10.2337/db08-022018443374Search in Google Scholar

4. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: Implications of the Accord, Advance and VA Diabetes Trials. Circulation 2009; 119: 351- 357.10.1161/CIRCULATIONAHA.108.19130519095622Search in Google Scholar

5. http://www.infostat.sk/vdc/sk/Search in Google Scholar

6. http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home/Search in Google Scholar

7. Tan HH, Chang JP. Non-alcoholic fatty liver disease proceedings of Singapore. Healthcare 2010; 19(1): 36 - 49.Search in Google Scholar

8. Wannamethee SG, Lennon L, Shaper AG. The value of gammaglutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008; 201: 168 - 175.10.1016/j.atherosclerosis.2008.01.01918378241Search in Google Scholar

9. Trappoliere M, Tuccillo C, Federico A et al. The treatment of NAFLD. Eur R Med Pharmacol Sci 2005; 9(5): 299-304.Search in Google Scholar

10. Giovannuci E, Harlan DM, Archer MC et al. Diabetes and cancer: a consensus report. CA Cancer Journal for Clinicians 2010; 60: 207 - 221.10.3322/caac.2007820554718Search in Google Scholar

11. Sun G, Kashyap SR. Cancer risk in type 2 diabetes mellitus: Metabolic links and therapeutic considerations. Journal of Nutrition and Metabolism 2011; 708183 E pub 2011 JUN 1. 12 Haluzík Martin, Haluzík Michal. Diabetes a nádory. In: Kvapil M, editors: Diabetologie 2011: 1nd ed. Praha: Vydavateľstvo Triton 2011; p. 32 - 45.10.1155/2011/708183313622121773024Search in Google Scholar

13. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126(2): 460 - 468.10.1053/j.gastro.2003.10.06514762783Search in Google Scholar

14. Galajda P, Mokáň M. Diabetes mellitus a nádory. Diabetes a obezita 2011; 11(20): 1-11.Search in Google Scholar

15. Scott M, Grund MD, Brewe B et al. Definition of metabolic syndrome. Circulation. 2004; 109: 433-438.10.1161/01.CIR.0000111245.75752.C614744958Search in Google Scholar

16. Definition of Metabolic Syndrome. Report of the National Heart, Lung, and Blood institute, American Heart Association. Conference on Scientific Issues Related to Definition. Clin. Biochem. Rev. 2004; 25 (3): 195 -198.Search in Google Scholar

17. http://www.idf.org/metabolic-syndromeSearch in Google Scholar

18. Sander D, Sander K, Poppert H. Stroke in type 2 diabetes. The British Journal of Diabetes and Vascular Disease 2008 ; 8: 222 - 229.10.1177/1474651408096677Search in Google Scholar

19. Taubert G, Winkelmann BR, Schleiffer T et al. Prevalence, predictors and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. American Heart Journal 2003; 145:285 -291.10.1067/mhj.2003.13412595846Search in Google Scholar

20. Lauruschkat AH, Arnrich B, Albert AA et al. Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing coronary artery bypass grafting. Circulation 2005; 112: 2397 - 2402.10.1161/CIRCULATIONAHA.105.53454516230496Search in Google Scholar

21. Vancheri F, Curcio M, Burgio A, et al. Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. Q J Med 2005; 98: 871 - 878.10.1093/qjmed/hci13416239309Search in Google Scholar

22. http://diabetes.niddk.nih.gov/DM/PUBS/statistics/#hds (National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH))Search in Google Scholar

23. Selvin E, Marinnopoulos S, Berkenblit G et al. Meta- analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421- 431.10.7326/0003-4819-141-6-200409210-0000715381515Search in Google Scholar

24. Jorgensen HS, Nakayma H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994; 25: 1977- 84.10.1161/01.STR.25.10.19778091441Search in Google Scholar

25. Bell RA, Mayer - Davis EJ et al. Associations between alcohol consumption and insulin sensivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 2000; 23:1630 -1660.10.2337/diacare.23.11.163011092284Search in Google Scholar

26. Facchini F, Chen YD, Reaven GM. Light - to moderate alcohol intake is associates with enhanced insulin sensivity. Diabetes Care 1994; 17: 115 - 119.10.2337/diacare.17.2.1157907975Search in Google Scholar

27. Mudra J, Rušavý Z: Alkohol a diabetes. Interní medicína pro prax 2004; 7: 347 - 351.Search in Google Scholar

28. http://www.diabetesatlas.org/content/diabetes (International Diabetes Federation )Search in Google Scholar

29. http://www.who.int/substance_abuse/publications/en/1_all_country_profiles_euro.pdf ( WHO Global Status Report on Alcohol 2004 )Search in Google Scholar

30. Petit JM, Guiu B, Terriat B et al. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. The Journal of Clinical Endocrinology and Metabolism 2009; 94 : 4103-6.10.1210/jc.2009-054119584186Search in Google Scholar

31. Szántová M. Metabolický syndróm a pečeň. Súč Klin Pr 2011; 2: 45-52.Search in Google Scholar

32. Perseghin G. Lipids in the wrong place: Visceral fat and nonalcoholic steatohepatitis: Diabetes Care 2011; 34 : S367- S370.10.2337/dc11-s249363220921525484Search in Google Scholar

33. Schindhelm RK, Dekker JM, Nijpels G, et al.: Alanine aminotransferase predict coronary heart disease events: a 10-years follow-up of the Hoorn Study. Atherosclerosis 2007; 191: 391-396.10.1016/j.atherosclerosis.2006.04.00616682043Search in Google Scholar

34. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Eng J Med 2010; 363(14): 1341-1350.10.1056/NEJMra091206320879883Search in Google Scholar

35. Kelishadi R, Cook SR, Adibi A, Faghihimani Z, Ghatrehsamani S, Beihaghi A, Salehi H, Khavarian N, Poursafa P: Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal- weight, overweight and obese children and adolescent. Diabetol Metab Syndr. 2009;1: 29.10.1186/1758-5996-1-29280560520028551Search in Google Scholar